JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CRNX
4001
CALL
DELISTED
Crinetics Pharmaceuticals
CRNX
| $1.24M | ﹤0.01% |
+34,900
| New | +$1.07M |
2023 Q4
0 quarters
|
|
|
FLNA
4002
Filana Therapeutics
FLNA
$45M
| $1.24M | ﹤0.01% |
55,129
+5,926
| +12% | +$125K |
2020 Q2
14 quarters
|
|
4003
Viridian Therapeutics
VRDN
$2.2B
| $1.24M | ﹤0.01% |
56,938
+6,016
| +12% | +$95K |
2021 Q4
8 quarters
|
|
4004
CALL
EQT Corp
EQT
$31.4B
| $1.24M | ﹤0.01% |
32,000
+31,500
| +6,300% | +$1.28M |
2020 Q3
13 quarters
|
|
4005
Riskified
RSKD
$1.04B
| $1.23M | ﹤0.01% |
263,126
+249,643
| +1,852% | +$1.02M |
2022 Q1
7 quarters
|
|
4006
WisdomTree US Multifactor Fund
USMF
$270M
| $1.23M | ﹤0.01% |
29,213
-7,583
| -21% | -$301K |
2022 Q4
4 quarters
|
|
4007
Mercury Systems
MRCY
$5.17B
| $1.23M | ﹤0.01% |
33,572
+4,524
| +16% | +$163K |
2016 Q2
30 quarters
|
|
4008
Peoples Bancorp
PEBO
$1.35B
| $1.23M | ﹤0.01% |
36,352
-50,085
| -58% | -$1.46M |
2016 Q4
28 quarters
|
|
|
CVAC
4009
CALL
DELISTED
CureVac
CVAC
| $1.22M | ﹤0.01% |
290,000
+168,200
| +138% | +$912K |
2023 Q3
1 quarter
|
|
|
PRSU
4010
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $1.22M | ﹤0.01% |
33,683
+2,992
| +10% | +$90.6K |
2013 Q2
42 quarters
|
|
|
PPLT
4011
abrdn Physical Platinum Shares ETF
PPLT
$2.07B
| $1.22M | ﹤0.01% |
133,750
+46,810
| +54% | +$395K |
2015 Q4
32 quarters
|
|
4012
Kodiak Gas Services
KGS
$5.49B
| $1.22M | ﹤0.01% |
60,599
+44,680
| +281% | +$804K |
2023 Q3
1 quarter
|
|
|
EWCZ
4013
DELISTED
European Wax Center
EWCZ
| $1.22M | ﹤0.01% |
89,511
+46,509
| +108% | +$674K |
2021 Q3
9 quarters
|
|
4014
TechTarget
TTGT
$258M
| $1.22M | ﹤0.01% |
34,874
+2,897
| +9% | +$85.7K |
2016 Q2
30 quarters
|
|
4015
Corsair Gaming
CRSR
$1.49B
| $1.22M | ﹤0.01% |
86,179
+36,802
| +75% | +$493K |
2020 Q3
13 quarters
|
|
4016
South Plains Financial
SPFI
$810M
| $1.21M | ﹤0.01% |
41,951
+7,827
| +23% | +$213K |
2019 Q2
18 quarters
|
|
4017
Navitas Semiconductor
NVTS
$3.26B
| $1.21M | ﹤0.01% |
150,533
+8,360
| +6% | +$56.1K |
2022 Q2
6 quarters
|
|
4018
ProShares S&P 500 High Income ETF
ISPY
$1.17B
| $1.21M | ﹤0.01% |
+30,000
| New | +$1.21M |
2023 Q4
0 quarters
|
|
4019
MasterCraft Boat Holdings
MCFT
$489M
| $1.21M | ﹤0.01% |
53,522
+29,453
| +122% | +$633K |
2017 Q4
24 quarters
|
|
4020
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.01B
| $1.21M | ﹤0.01% |
65,004
+6,896
| +12% | +$126K |
2021 Q4
8 quarters
|
|
4021
PUT
Moderna
MRNA
$75.9B
| $1.2M | ﹤0.01% |
12,100
| – | – |
2020 Q1
15 quarters
|
|
|
TWKS
4022
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.2M | ﹤0.01% |
248,922
+126,681
| +104% | +$520K |
2021 Q4
8 quarters
|
|
4023
CALL
Global Payments
GPN
$20.7B
| $1.19M | ﹤0.01% |
9,400
| – | – |
2023 Q2
2 quarters
|
|
|
4024
PUT
Global Payments
GPN
$20.7B
| $1.19M | ﹤0.01% |
9,400
| – | – |
2023 Q2
2 quarters
|
|
|
MTTR
4025
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.19M | ﹤0.01% |
442,685
+124,811
| +39% | +$300K |
2021 Q3
9 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.